Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of etelcalcetide cas 1262780-97-1 in China. Welcome to wholesale bulk high quality etelcalcetide cas 1262780-97-1 for sale here from our factory. Good service and reasonable price are available.
Etelcalcetide is a white or almost white crystalline powder, sometimes also a light yellow color. It is usually odorless and soluble in water. The chemical formula is C26H27N5O2, with a relative molecular weight of 445.531 g/mol. It is an antidepressant drug that is a selective serotonin reuptake inhibitor (SSRI) and a partial agonist of the serotonin 1A receptor. It has optical rotation, with a rotation angle of+30 ° to+35 ° (10mg/ml, in water). It is a chiral molecule that may form different enantiomers during chemical synthesis. Due to the presence of enantiomers, there may be differences in their optical rotation and other optical properties. The infrared spectrum shows characteristic absorption peaks, and the stretching vibration absorption peak of NH can be observed at approximately 3400 cm-1; A stretching vibration absorption peak of CH3 can be observed at approximately 2920 cm-1; A stretching vibration absorption peak of CO can be observed at approximately 1650 cm-1; A stretching vibration absorption peak of the aromatic ring can be observed at approximately 1500 cm-1.
|
Customized Bottle Caps And Corks:
|
|

|
Chemical Formula |
C38H73N21O10S2 |
|
Exact Mass |
1048 |
|
Molecular Weight |
1048 |
|
m/z |
1048 (100.0%), 1049 (41.1%), 1050 (9.0%), 1050 (8.2%), 1049 (7.8%), 1051 (3.7%), 1050 (3.2%), 1050 (2.1%), 1049 (1.6%), 1051 (1.1%) |
|
Elemental Analysis |
C, 43.54; H, 7.02; N, 28.06; O, 15.26; S, 6.12 |

Etelcalcetide is an effective oral dipeptidyl peptidase 4 (DPP-4) inhibitor, mainly used to treat type 2 diabetes. As a new type of anti diabetes drug, it has many functions, which are of great significance to improve the blood sugar control and life quality of diabetes patients.
1. Reduce blood sugar levels
The main function is to lower blood sugar levels. It reduces the degradation of glucagon like peptide-1 (GLP-1) and glucose dependent insulinotropic peptides (GIP) in the body by inhibiting the activity of DPP-4 enzyme, thereby increasing the physiological activity of these intestinal pro-insulins. GLP-1 and GIP can promote insulin secretion, inhibit the release of glucagon, and thereby lower blood sugar levels. This effect of Veracatide is helpful to improve the blood sugar control of diabetes patients and reduce the occurrence of complications.
2. Improve insulin resistance

Insulin resistance is one of the important pathophysiological characteristics of type 2 diabetes. Its substance improves insulin resistance by increasing insulin sensitivity. It can promote the uptake and utilization of insulin by adipocytes and muscle cells, enhance the biological activity of insulin, and thus enhance the body's sensitivity to insulin. This effect helps to reduce blood sugar levels and reduce the need for insulin in patients with diabetes.
3. Promotion β Cell regeneration and functional recovery
It also has the function of promoting pancreatic islets β The role of cell regeneration and functional recovery. By inhibiting the activity of DPP-4 enzyme, protection can be achieved β Cells are protected from damage factors such as high blood sugar and oxidative stress, promoting β The survival and proliferation of cells. In addition, it can also increase β The synthesis and secretion of intracellular insulin, improving β The functional activity of cells. These effects are helpful to improve the islet function of patients with diabetes and increase the level of insulin secretion.
4. Reduce weight and fat accumulation
It also has the effect of reducing weight and fat accumulation. It can reduce appetite and food intake, and lower energy intake. At the same time, veracalide can also promote the breakdown and metabolism of fat, reducing the accumulation of fat in the body. This effect can help to improve the obesity of diabetes patients and reduce the risk of cardiovascular disease and other complications.
5. Improve blood lipid metabolism
It can also improve blood lipid metabolism and lower blood lipid levels. It can increase the synthesis and secretion of high-density lipoprotein (HDL), and reduce the levels of low-density lipoprotein (LDL) and total cholesterol (TC). In addition, it can also inhibit the synthesis and accumulation of triglycerides, and reduce the level of triglycerides in plasma. These effects help reduce the risk of cardiovascular disease in patients with diabetes.
6. Protecting the cardiovascular system
It also has a protective effect on the cardiovascular system. It can lower blood pressure, reduce the occurrence of cardiovascular diseases such as heart hypertrophy and myocardial damage. In addition, it can also inhibit the inflammatory and oxidative stress responses of endothelial cells, protecting the health and integrity of blood vessel walls. These effects help to reduce the risk of cardiovascular disease in patients with diabetes and improve the quality of life.
7. Improve cognitive function
Recent studies have shown that it also has the effect of improving cognitive function. It can increase the content and activity of neurotransmitters in the brain, such as acetylcholine and dopamine, and improve the excitability and information transmission efficiency of neurons. In addition, it can also inhibit inflammation and oxidative stress reactions in the brain, protecting the health and survival of neurons. These effects are helpful to improve the cognitive dysfunction of diabetes patients and improve the quality of life.
8. Improve quality of life
In summary, by reducing blood sugar levels, improving insulin resistance, and promoting β Cell regeneration and functional recovery, weight reduction and fat accumulation reduction, lipid metabolism improvement, cardiovascular system protection, cognitive function improvement and other effects provide a comprehensive and effective treatment for diabetes patients. The exertion of these functions will help to improve the blood sugar control and quality of life of patients with diabetes, reduce the risk of complications, and improve the survival rate and health level of patients. Therefore, Veracatide has important clinical value and application prospect in the treatment of diabetes.

Etelcalcetide is a dipeptidyl peptidase 4 (DPP-4) inhibitor, which is mainly used to treat type 2 diabetes. Its synthesis involves multiple steps, and the following will provide a detailed introduction to its common laboratory synthesis methods and corresponding chemical equations.

Synthesis steps:
1. Activation of amino acids
Firstly, it is necessary to select appropriate amino acids for activation. The commonly used activation method is to activate carboxyl groups using N-hydroxysuccinimide (NHS) and N, N '- dicyclohexylcarbodiimide (DCC).
Chemical equation (using L-alanine as an example):
C3H7NO2+C4H5NO3+C13H22N2 → C3H7NO2NHS+C13H24N2O
Among them, DCU is N, N '- dicyclohexylurea, which is a byproduct of the reaction.
2. Condensation reaction
The activated amino acid undergoes a condensation reaction with the amino group of the next amino acid to form a peptide bond. This step is usually carried out under alkaline conditions, such as using triethylamine as a base.
Chemical equation (using L-alanine and L-leucine as examples):
C3H7NO2-NHS+C6H13NO2+C6H15N → C3H7NO2-L-C6H13NO2+H2O+NHS - triethylamine salt
3. Extension of peptide chains
By repeating the condensation reaction, gradually connect the required amino acids to the peptide chain until the complete sequence of veracalide is obtained.
4. Cyclization reaction
Veracapeptide molecules contain a specific cyclic structure that needs to be formed through cyclization reactions. This usually involves a reaction between one side chain group and another group on the peptide chain.
Chemical equation (using a simplified fragment of veracalide as an example):
H2N peptide chain CO-R1+peptide chain CO-R2 → [H2N peptide chain CO-R1] - peptide chain CO-R2+H2O
R1 and R2 represent different functional groups on the peptide chain, forming a cyclic structure through reaction.
5. Purification and crystallization
After completing the cyclization reaction, the product needs to be purified and crystallized to obtain high-purity veracalide. This usually involves steps such as column chromatography, thin-layer chromatography, and recrystallization.

The development prospects of Etelcalcetide are very broad, mainly based on its significant therapeutic effects and unique mechanism of action in the medical field. The following is a detailed analysis of its development prospects:
Significant medical efficacy
This compound serves as an innovative calcium sensitive receptor (CaSR) activator, effectively inhibiting the proliferation of parathyroid cells and the secretion of parathyroid hormone (PTH) by enhancing the sensitivity of CaSR to calcium ions. This mechanism of action enables Etelcalcetide to demonstrate significant efficacy in the treatment of secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD). SHPT is one of the common complications in CKD patients, characterized by abnormally elevated PTH levels, which not only lead to bone structure damage but also accelerate vascular calcification and increase the risk of cardiovascular disease. It can significantly reduce the concentration of PTH in patients' bodies, improve bone and mineral metabolism, thereby slowing down disease progression and improving patients' quality of life.
Huge market potential
The demand of patients increases: With the increasing number of CKD patients, the incidence rate of SHPT also increases accordingly, and the demand for this compound will continue to grow.
Medical insurance policy support: In many countries and regions, it can be partially or fully paid through medical insurance, which reduces the economic burden on patients and improves the accessibility of drugs.
There are few competitors: Currently, there are few similar drugs on the market, and as a new type of drug, this compound has a large market space and competitive advantage.
Rapid progress in research and development
Clinical trial success: This compound has been successfully tested in multiple clinical trials, demonstrating its safety and efficacy.
New drug launch: It has been approved for marketing in the European Union, the United States, and China for the treatment of SHPT in CKD adult patients undergoing hemodialysis.
Continuous research and development: Pharmaceutical companies are continuing to explore other potential uses of this compound, such as osteoporosis, primary hyperparathyroidism, and other diseases related to abnormal calcium and phosphorus metabolism, which will further expand its market space.
Policy support and promotion
National policy: Governments around the world are increasing their support for the pharmaceutical industry, promoting the development of new drugs and the launch of innovative drugs.
International Cooperation: The increasing frequency of cooperation and communication between multinational pharmaceutical companies will promote the global promotion and application of this compound.
Hot Tags: etelcalcetide cas 1262780-97-1, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, naphtholbenzein indicator, 4 4 5 5 tetramethyl 2 7 phenyl d5 dibenzo b d furan 1 yl 1 3 2 dioxaborolane, CAS 50548 45 3, 1-Bromophenanthrene, CAS 162607 19 4, 9H-carbazole-4-carbonitrile







